Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%
In
Investing.comBy Investing.com10/30/2026, 10:43:08 AM
EXECUTIVE SUMMARY
Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%....
Key Takeaways
- Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4%.
Read Complete Original Article
Published originally on Investing.com
Related News
finance14 minutes ago
Gold price falls by Rs5,100 per tola in Pakistan
Gold price falls by Rs5,100 per tola in Pakistan Business Recorder
finance15 minutes ago
AutoNation shares gain 5% on revenue beat despite earnings miss By Investing.com
AutoNation shares gain 5% on revenue beat despite earnings miss By Investing.com Investing.com Australia
finance19 minutes ago
Gold price today, Friday, October 30, 2026: Gold slips below $4,000 as Mid-East concerns mount
Gold price today, Friday, October 30, 2026: Gold slips below $4,000 as Mid-East concerns mount Yahoo Finance
finance21 minutes ago
AutoNation shares gain 5% on revenue beat despite earnings miss
AutoNation shares gain 5% on revenue beat despite earnings miss....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!